A J Carter
Affiliation: Stanford University
- Dose and dose rate effects of beta-particle emitting radioactive stents in a porcine model of restenosisA J Carter
Experimental Coronary Intervention Laboratories, Stanford University Medical Center, California 94305 5218, USA
Cardiovasc Radiat Med 1:327-35. 1999..Radioactive stents have been proposed as a means to prevent in-stent restenosis by inhibiting intimal proliferation with continuous low-dose irradiation...
- The effects of uncontrolled hyperglycemia on thrombosis and formation of neointima after coronary stent placement in a novel diabetic porcine model of restenosisA J Carter
Experimental Coronary Intervention Laboratories, Stanford University Medical Center, CA 94305 5218, USA
Coron Artery Dis 11:473-9. 2000..The mechanism for this exaggerated neointimal response is not known...
- Experimental evaluation of a short transitional edge protection balloon for intracoronary stent deploymentA J Carter
Stanford University Medical Center, Stanford, California 94305, USA
Catheter Cardiovasc Interv 51:112-9. 2000..These experimental data suggest that further study is warranted to refine stent implantation techniques and that modifications of balloon shape or material may be useful to optimize stent deployment and reduce arterial trauma...
- Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary modelT Suzuki
Stanford University Medical Center, Stanford, California, USA
Circulation 104:1188-93. 2001..CONCLUSIONS: Stent-based delivery of SRL via a nonerodable polymer matrix is feasible and effectively reduces in-stent neointimal hyperplasia by inhibiting cellular proliferation...
- The drug-eluting stent: is it the Holy Grail?B L Hiatt
Division of Cardiovascular Medicine, Stanford University Medical Center, Stanford, CA, USA
Rev Cardiovasc Med 2:190-6. 2001..Currently ongoing, multicenter clinical trials of drug-eluting stents may soon come up with the answers that cardiologists have been hoping for...